D. Mascia, G. Esposito, A. Ferrante, A. Grandi, G. Melissano, R. Chiesa
{"title":"颈动脉体肿瘤在高容量中心的当代治疗。","authors":"D. Mascia, G. Esposito, A. Ferrante, A. Grandi, G. Melissano, R. Chiesa","doi":"10.23736/S0021-9509.19.10496-X","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nThe aim of this study is to report our results with carotid body tumour (CBT) surgical management.\n\n\nMETHODS\nBetween 2010 and 2018, 100 CBTs (mean age: 48.0 years, range 21-80 years old) were treated in our centre. The patients were classified in 3 groups according to the size: group I (< 3cm), group II (3 to 5 cm) and group III (>5 cm).\n\n\nRESULTS\nSurgical resection was performed in 88 patients and conservative treatment in 2 cases. Nine patients were treated for bilateral involvement and one of them was also treated again for a relapse. Postoperatively, cranial nerve injury (CNI) was significantly higher in group II [3 (8.3%) vs 16 (31.4%) vs 2 (15.4%); p = 0.030] with no statistical differences between the CN involved. At univariate analysis for CNI, CBT group (p=0.030), maximum diameter (p=0.046), patients presenting with dysphonia (p=0.035) and dysphagia (p=0.007) and patients suffering from any intraoperative complication (p=0.047) were statistically significant. At multivariate analysis the only significant variable was CBT group II (p=0.016). For blood loss, CBT group III (p<0.001), Shamblin class III (p<0.001), Pulmonary disease (p=0.034) and surgery time (p<0.001) were statistically significant. The follow-up of 79 patients (87.8%) showed a 100% overall survival at median follow-up of 37.7 months (range 2-84.7 months) with freedom from local recurrence of 97.8% (77/79).\n\n\nCONCLUSIONS\nSurgical resection remains the gold standard to obtain complete recovery, although tumour size is to be considered a risk factor for CNI because large CBTs remain at high risk for CNIs.","PeriodicalId":101333,"journal":{"name":"The Journal of cardiovascular surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Carotid body tumor contemporary management in a high-volume centre.\",\"authors\":\"D. Mascia, G. Esposito, A. Ferrante, A. Grandi, G. Melissano, R. Chiesa\",\"doi\":\"10.23736/S0021-9509.19.10496-X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND\\nThe aim of this study is to report our results with carotid body tumour (CBT) surgical management.\\n\\n\\nMETHODS\\nBetween 2010 and 2018, 100 CBTs (mean age: 48.0 years, range 21-80 years old) were treated in our centre. The patients were classified in 3 groups according to the size: group I (< 3cm), group II (3 to 5 cm) and group III (>5 cm).\\n\\n\\nRESULTS\\nSurgical resection was performed in 88 patients and conservative treatment in 2 cases. Nine patients were treated for bilateral involvement and one of them was also treated again for a relapse. Postoperatively, cranial nerve injury (CNI) was significantly higher in group II [3 (8.3%) vs 16 (31.4%) vs 2 (15.4%); p = 0.030] with no statistical differences between the CN involved. At univariate analysis for CNI, CBT group (p=0.030), maximum diameter (p=0.046), patients presenting with dysphonia (p=0.035) and dysphagia (p=0.007) and patients suffering from any intraoperative complication (p=0.047) were statistically significant. At multivariate analysis the only significant variable was CBT group II (p=0.016). For blood loss, CBT group III (p<0.001), Shamblin class III (p<0.001), Pulmonary disease (p=0.034) and surgery time (p<0.001) were statistically significant. The follow-up of 79 patients (87.8%) showed a 100% overall survival at median follow-up of 37.7 months (range 2-84.7 months) with freedom from local recurrence of 97.8% (77/79).\\n\\n\\nCONCLUSIONS\\nSurgical resection remains the gold standard to obtain complete recovery, although tumour size is to be considered a risk factor for CNI because large CBTs remain at high risk for CNIs.\",\"PeriodicalId\":101333,\"journal\":{\"name\":\"The Journal of cardiovascular surgery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of cardiovascular surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S0021-9509.19.10496-X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of cardiovascular surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0021-9509.19.10496-X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Carotid body tumor contemporary management in a high-volume centre.
BACKGROUND
The aim of this study is to report our results with carotid body tumour (CBT) surgical management.
METHODS
Between 2010 and 2018, 100 CBTs (mean age: 48.0 years, range 21-80 years old) were treated in our centre. The patients were classified in 3 groups according to the size: group I (< 3cm), group II (3 to 5 cm) and group III (>5 cm).
RESULTS
Surgical resection was performed in 88 patients and conservative treatment in 2 cases. Nine patients were treated for bilateral involvement and one of them was also treated again for a relapse. Postoperatively, cranial nerve injury (CNI) was significantly higher in group II [3 (8.3%) vs 16 (31.4%) vs 2 (15.4%); p = 0.030] with no statistical differences between the CN involved. At univariate analysis for CNI, CBT group (p=0.030), maximum diameter (p=0.046), patients presenting with dysphonia (p=0.035) and dysphagia (p=0.007) and patients suffering from any intraoperative complication (p=0.047) were statistically significant. At multivariate analysis the only significant variable was CBT group II (p=0.016). For blood loss, CBT group III (p<0.001), Shamblin class III (p<0.001), Pulmonary disease (p=0.034) and surgery time (p<0.001) were statistically significant. The follow-up of 79 patients (87.8%) showed a 100% overall survival at median follow-up of 37.7 months (range 2-84.7 months) with freedom from local recurrence of 97.8% (77/79).
CONCLUSIONS
Surgical resection remains the gold standard to obtain complete recovery, although tumour size is to be considered a risk factor for CNI because large CBTs remain at high risk for CNIs.